MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ACRS has $198,720K in assets. $55,071K in debts. $28,660K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
402.74%
Quick Ratio
402.74%
Cash Ratio
104.71%
Debt to Asset Ratio
27.71%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Short-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paidin capital
    • Accumulated deficit
    • Deferred income, net of current ...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Prepaid expenses and other current assets
---4,202
Cash and cash equivalents
28,660 19,960 25,256 25,402
Short-term marketable securities
76,756 70,791 70,656 74,404
Accounts receivable, net
---194
Accounts receivable, prepaid expenses and other current assets
4,814 5,565 4,680 -
Total current assets
110,230 96,316 100,592 104,202
Marketable securities
85,372 60,612 71,297 81,084
Property and equipment, net
750 761 811 868
Other assets
2,368 2,771 2,834 2,993
Total assets
198,720 160,460 175,534 189,147
Accounts payable
14,731 13,158 9,187 8,797
Accrued expenses
5,896 8,791 9,784 11,411
Deferred income
3,972 3,943 3,925 3,914
Other current liabilities
2,771 2,753 2,735 2,717
Total current liabilities
27,370 28,645 25,631 26,839
Other liabilities
1,416 1,565 1,711 1,851
Deferred income, net of current portion
15,285 16,168 17,492 18,218
Contingent consideration
11,000 11,000 10,600 10,500
Total liabilities
55,071 57,378 55,434 57,408
Common stock, 0.00001 par value 400,000,000 shares authorized at march 31, 2026 and december 31, 2025 139,652,849 and 120,499,433 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
1 1 1 1
Additional paidin capital
1,131,234 1,070,255 1,067,491 1,064,631
Accumulated other comprehensive income
22 610 597 482
Accumulated deficit
-987,608 -967,784 -947,989 -933,375
Total stockholders' equity
143,649 103,082 120,100 131,739
Total liabilities and stockholders' equity
198,720 160,460 175,534 189,147
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$76,756K Cash and cashequivalents$28,660K Accounts receivable,prepaid expenses and...$4,814K Total current assets$110,230K Marketable securities$85,372K Other assets$2,368K Property and equipment,net$750K Total assets$198,720K Total liabilities andstockholders' equity$198,720K Total stockholders'equity$143,649K Total liabilities$55,071K Accumulated deficit-$987,608K Additional paidin capital$1,131,234K Total currentliabilities$27,370K Deferred income, net ofcurrent portion$15,285K Contingent consideration$11,000K Other liabilities$1,416K Accumulated othercomprehensive income$22K Common stock, 0.00001par value...$1K Accounts payable$14,731K Accrued expenses$5,896K Deferred income$3,972K Other currentliabilities$2,771K

Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics, Inc. (ACRS)